Canada Inflammatory Bowel Disease (IBD) Market Size, Share & Forecast to 2025


Posted April 15, 2020 by rishabh3210

Canada Inflammatory Bowel Disease (IBD) Market Size, Share & Forecast to 2025Canada Inflammatory Bowel Disease (IBD) Market Size, Share & Forecast to 2025

 
The Canada IBD market is estimated to grow significantly at a CAGR of around 5.2% during the forecast period. Rising prevalence and incidence of IBD across the country is the major driving factor for the market. Canada has among the highest reported prevalence and incidence rates of IBD across the globe. As per CCC, in 2018, nearly 270,000 Canadians were living with IBD, of which 135,000 individuals with Crohn’s disease, 120,000 with ulcerative colitis, and 15,000 with IBD type unclassified (IBD-U). CCC further estimates that seven out of every 1,000 Canadians has IBD. Moreover, by 2030, the number of people living with IBD is expected to rise to over 400,000, or nearly 1% of the population. The highest reported incidence of IBD is in Nova Scotia at 54.6 per 100,000 new cases per year, and the lowest is in British Columbia at 18.7 per 100,000 people per year.

Get Free Sample Copy @ https://www.omrglobal.com/request-sample/canada-ibd-inflammatory-bowel-disease-market

Canada IBD market is segmented on the basis of disease type, diagnostics, and therapeutics. Canada IBD market is segmented on the basis of disease type into ulcerative colitis and Crohn’s disease. Crohn’s disease segment is estimated to dominate the market. The growth of the segment is attributed to the comparatively higher incidence of Crohn’s disease than ulcerative colitis. On the basis of diagnostics, the market segmented into blood and stool, endoscopies, ultrasound, and X-rays. Endoscopy is a conventional diagnostic method that is widely being used for the diagnosis of IBD and having a considerable share in the market.

A Full Report of Canada Inflammatory Bowel Disease (IBD) Market is Available at: https://www.omrglobal.com/industry-reports/canada-ibd-inflammatory-bowel-disease-market

The companies which are contributing to the growth of the Canada IBD market include Abbott Laboratories, AbbVie Inc., Accesa Labs, Celgene Corp., Eli Lilly and Co., Johnson & Johnson Services Inc., Laboratory Corporation of America Holdings, Pfizer Inc., and others.

For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/canada-ibd-inflammatory-bowel-disease-market

Market Segmentation

Canada IBD Market Research and Analysis by Disease Type
Canada IBD Market Research and Analysis by Diagnostics
Canada IBD Market Research and Analysis by Therapeutics

Secondary Sources Include

Financial reports of companies involved in the market.
Whitepapers, research-papers, and news blogs.
Company websites and their product catalog.

About Orion Market Research

Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.

Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: [email protected]
Contact no: +1 646-755-7667, +91 780-304-0404
-- END ---
Share Facebook Twitter
Print Friendly and PDF DisclaimerReport Abuse
Contact Email [email protected]
Issued By Mr. Anurag Tiwari
Phone +1 646-755-7667
Country India
Categories Business
Tags canada inflammatory bowel disease ibd market size , share forecast to 2025
Last Updated April 15, 2020